NPI registry status
Active
2026 NPPES data Addiction Medicine (Internal Medicine) Physician NPI 1033173471 M.D.
Verify on CMS → Mikhail Artamonov, M.D.
Addiction Medicine (Internal Medicine) Physician in East Stroudsburg, Pennsylvania.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 571 in Addiction Medicine (Internal Medicine) Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
416
Medicare Part D claims · 71 beneficiaries · Addiction Medicine (Internal Medicine) Physician avg: 1K
Generic prescribing
95%
generic claims · 5% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$113.2
6 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Mikhail Artamonov, M.D. filed 416 Medicare Part D claims in 2024 as an Addiction Medicine (Internal Medicine) Physician in East Stroudsburg, Pennsylvania, prescribing 95% generic.
- 416
- Part D claims, 2024
- 95%
- generic prescribing
- $113.2
- industry payments (Sunshine Act)
- ≥61st
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Mikhail Artamonov, M.D.
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1033173471), first enumerated 04/13/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 416 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Practices in an ABMS-board-eligible specialty; board certification not confirmed in federal records.
- Reported
Industry payment transparency
$113.2 in reported industry payments (6 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
Pennsylvania statewide board action statistics are published annually — these figures describe aggregate state activity, not Mikhail Artamonov, M.D.'s individual license status. Verify directly with the state medical board.
Source: PA-BOM annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
Compare Artamonov with other Addiction Medicine (Internal Medicine) Physician providers
Same primary specialty, same federal CMS NPPES roster.
Also enrolled in Pennsylvania
- Dr. James Berman, M.D. Merion Station, PA
- Dr. Mario Cassara, MD Pittsburgh, PA
- Catherine Chappell Pittsburgh, PA
- Dr. Julie Childers, MD Pittsburgh, PA
- Dr. Christopher Davis, D.O. York, PA
- Dr. Melina Diaz Pellot, DO Philadelphia, PA
Other specialties in East Stroudsburg: Athletic Trainer (70) · Pharmacist (47) · Physician Assistant (44) · Family Nurse Practitioner (37)
CMS NPPES provider registry desk
NPI 1033173471 · Addiction Medicine (Internal Medicine) Physician
NPI-10 · ENUM-LEGACY · TAX-NARROW · RX-LIGHT · BOOK-THIN · PHOTO-ENUM
- NPI-10 1033173471
- ENUM-LEGACY 2006
- TAX-NARROW 571
- RX-LIGHT 416
- BOOK-THIN 31 in Pennsylvania
- PHOTO-ENUM Michel Antoine, M.D. · 2006
Mikhail Artamonov, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
416 ≥ 61st percentile 61% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
◑
Board-eligible specialty (heuristic, not verified)
Mikhail Artamonov, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Mikhail Artamonov, M.D.?
Quality data not reportedPrimary specialty
Addiction Medicine (Internal Medicine) Physician
Medicare Part D claims
416 71% vs specialty avg
Specialty distribution in Pennsylvania
How Addiction Medicine (Internal Medicine) Physician compares to other specialties among Pennsylvania providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Addiction Medicine (Internal Medicine) Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1033173471 |
|---|---|
| Specialty | Addiction Medicine (Internal Medicine) Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 04/13/2006 |
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Mikhail Artamonov, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$113
Largest payer
Boston Scientific Corporation
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Pennsylvania PA-BOM 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~45K Pennsylvania medical licensees in 2023 - they are NOT specific to Mikhail Artamonov, M.D.. To verify Mikhail Artamonov, M.D.'s current license status, search the PA-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
133
Total board actions, Pennsylvania 2023
Across 129 cases
2.96
Actions per 1,000 licensees
Pennsylvania statewide rate
probation
Most common action type
48 cases
PA-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Pennsylvania disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Generic-heavy
Mikhail Artamonov, M.D. - brand share 5.0%
Addiction Medicine (Internal Medicine) Physician average
5% brand-name claims vs 95% generic, on 416 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
416
Total Claims
$19K
Total Drug Cost
71
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 514
- Total Day Supply
- 13,894
- Brand vs Generic
- 5% brand / 95% generic
- Brand Drug Cost
- $13K
- Generic Drug Cost
- $6K
- Opioid Claims
- 46 (11.1% rate)
- Antibiotic Claims
- 15
Patient Demographics
- Average Patient Age
- 65.5 years
- Avg HCC Risk Score
- 1.37
- Gender Split
- 56% female / 44% male
- Age Distribution
- <65: 30, 65-74: 27, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Mikhail Artamonov, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Gabapentin
Gabapentin
75 claims
- Tizanidine Hcl
Tizanidine Hcl
44 claims
- Meloxicam
Meloxicam
32 claims
- Duloxetine Hcl 26
Duloxetine Hcl
26 claims
- Oxycodone-Acetamin… 23
Oxycodone-Acetaminophen
23 claims
- Zolpidem Tartrate 20
Zolpidem Tartrate
20 claims
- Cyclobenzaprine Hcl 17
Cyclobenzaprine Hcl
17 claims
- Methocarbamol 15
Methocarbamol
15 claims
| Drug | Claims |
|---|---|
| Gabapentin | 75 |
| Tizanidine Hcl | 44 |
| Meloxicam | 32 |
| Duloxetine Hcl | 26 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 23 |
| Zolpidem Tartrate | 20 |
| Cyclobenzaprine Hcl | 17 |
| Methocarbamol | 15 |
| Butalbital-Acetaminophen-Caffe Butalb/Acetaminophen/Caffeine | 12 |
| Lidocaine | 12 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Addiction Medicine (Internal Medicine) Physician in PA →
All providers in Pennsylvania →
Compare specialties →
Addiction Medicine (Internal Medicine) Physician Overview
How Mikhail Artamonov, M.D. fits within the Addiction Medicine (Internal Medicine) Physician landscape nationally.
571
Addiction Medicine (Internal Medicine) Physician Providers in US
46
States with Addiction Medicine (Internal Medicine) Physician
1,455
Avg Claims per Provider
Mikhail Artamonov, M.D.'s 416 claims are below the specialty average of 1,455.
Nationwide Addiction Medicine (Internal Medicine) Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Artamonov, both outside Pennsylvania so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Addiction Medicine (Internal Medicine) Physician Providers in Pennsylvania
Other clinicians with the same primary specialty enrolled in Pennsylvania, drawn from the same CMS NPPES roster as Artamonov.
One of 31 Addiction Medicine (Internal Medicine) Physician providers enrolled in Pennsylvania, 11 are shown on this page.
Frequently Asked Questions
What is Mikhail Artamonov, M.D.'s specialty? ▼
Mikhail Artamonov, M.D. specializes in Addiction Medicine (Internal Medicine) Physician and practices in East Stroudsburg, Pennsylvania. Credentials: M.D..
How much does Mikhail Artamonov, M.D. prescribe under Medicare Part D? ▼
In 2024, Mikhail Artamonov, M.D. wrote 416 Medicare Part D claims totaling $19K in drug costs for 71 beneficiaries.
Where is Mikhail Artamonov, M.D. located? ▼
Mikhail Artamonov, M.D. is located at 391 E BROWN ST, East Stroudsburg, PA, 18301. Phone: (570) 872-9800.
What is Mikhail Artamonov, M.D.'s NPI number? ▼
Mikhail Artamonov, M.D.'s National Provider Identifier (NPI) is 1033173471, issued on 04/13/2006.
Does Mikhail Artamonov, M.D. prescribe more brand-name or generic drugs? ▼
Mikhail Artamonov, M.D.'s prescribing is 5% brand-name and 95% generic drugs by claim count, with $13K in brand drug costs.
Does Mikhail Artamonov, M.D. prescribe opioids? ▼
Yes, Mikhail Artamonov, M.D. had 46 opioid claims in 2024 with an opioid prescribing rate of 11.1%.
How many Addiction Medicine (Internal Medicine) Physician providers are there in the US? ▼
There are 571 Addiction Medicine (Internal Medicine) Physician providers across 46 states in the US. The average Addiction Medicine (Internal Medicine) Physician provider writes 1,455 Medicare Part D claims per year.
What drugs does Mikhail Artamonov, M.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, Mikhail Artamonov, M.D.'s most frequently prescribed drugs include Gabapentin, Tizanidine Hcl, Meloxicam. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Mikhail Artamonov, M.D. accept Medicare? ▼
Mikhail Artamonov, M.D. appears in CMS Medicare data with 416 Part D claims and 71 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Mikhail Artamonov, M.D.'s credentials? ▼
Mikhail Artamonov, M.D.'s NPI is 1033173471 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.